Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2009; 134(45): 2278-2282
DOI: 10.1055/s-0029-1241939
DOI: 10.1055/s-0029-1241939
Übersicht | Review article
Hypertensiologie© Georg Thieme Verlag KG Stuttgart · New York
Baroreflexstimulation bei therapierefraktärer arterieller Hypertonie
Baroreflex stimulation for resistant arterial hypertensionFurther Information
Publication History
eingereicht: 1.7.2009
akzeptiert: 16.10.2009
Publication Date:
29 October 2009 (online)

Schlüsselwörter
therapierefraktäre Hypertonie - Baroreflexstimulation
Keywords
resistant hypertension - baroreflex hypertension therapy
Literatur
- 1
Bisognamo J, De Leeuw P, Bach D S. et al .
Improved cardiac structure and function
in early-stage heart failure with chronic treatment using an implantable
Device: Results from the European and United States Trials of the
Rheos system.
J Cardiac Failure.
2008;
14
S48
MissingFormLabel
- 2
Bisognamo J, De Leeuw P, Irwin E. et al .
Long term baroreflex hypertension therapy
significantly lowers ambulatory blood pressure in patients with
resistant hypertension.
Clin Hypertens.
2008;
10
A117
MissingFormLabel
- 3
Calhoun D, Jones D, Textor S. et al .
Resistant hypertension: diagnosis, evaluation,
and treatment: a sientific statement from the American Heart Association
Professional Education Committee of the Council for High Blood Pressure
Research.
Hypertension.
2008;
51
1403-1419
MissingFormLabel
- 4 Chusid J G. Funktionelle Neurologie. Berlin, Heidelberg, New York; Springer Verlag 1978: 109-15
MissingFormLabel
- 5
De Leeuw P, Bisognamo J, Bach D S. et al .
Deviced-based reduction in blood pressure
is associated with increased diameter of the left ventricular outflow
tract: Results from the European and United States Trials of the
Rheos( System.
Circulation.
2008;
118
S887
MissingFormLabel
- 6
De Leeuw P, Bisognamo J, Bach D S. et al .
Improved cardiac structure and diastolic
flow velocities in early-stage heart failure with chronic treatment
using an implantable Device: Results from the European and United
States Trials of the Rheos( System.
J Am Coll Cardiol.
2009;
53
A188
MissingFormLabel
- 7
De Leeuw P, Gangahar D, Bach D S. et al .
Left ventricular reverse remodeling with
chronic treatment using an implantable device: Results from the
European and United States trials of the Rheos( Baroreflex Hypertension
Therapy System.
J Hypertens.
2008;
26
(Suppl 1)
S471
MissingFormLabel
- 8
De Leeuw P, Kroon A A, Scheffers I. et al .
Baroreflex hypertension therapy with a
chronically implanted system: Preliminary efficicay and safety results
from the Rheos DEBuT-HT study in patients with resistant hypertension.
J Hypertens.
2006;
24
(Suppl. 4)
S300-S3001
MissingFormLabel
- 9
Green A L, Wang S, Owen S L. et al .
Stimulating the human midbrain to reveal
the link between pain and blood pressure.
Pain.
2006;
124
349-59
MissingFormLabel
- 10
Griffith L CS, Schwartz S I.
Electrical
stimulation of the carotid sinus nerve in normotensive and renal
hypertensive dogs.
Circulation.
1963;
28
730
MissingFormLabel
- 11
Hamberger C A, Carlsten A, Folkow B. et al .
Some cardiovascular observation during
radical neck dissection.
Cancer.
1957;
10
938-43
MissingFormLabel
- 12
Heusser K, Tank J, Diedrich A. et al .
Electrical carotid sinus stimulation reduces
symphatetic activity and blood pressure in patients with refractory
hypertension.
J Hypertens.
2009;
27
(Suppl 1)
S 288
MissingFormLabel
- 13
Lohmeier T E, Dwyer T M, Hildebrandt D A. et al .
Suppression of the renin-angiotensin
system contributes by prolonged baroreflex activation.
Hypertension.
2004;
44
500
MissingFormLabel
- 14
Lohmeier T E, Irwin E D, Rossing M A. et al .
Prolonged activation of
the baroreflex produces sustainede hypotension.
Hypertension.
2004;
43
306-11
MissingFormLabel
- 15
Mancia G, De Backer G, Dominczak A. et al .
Guidelines for the mangagement of arterial
hypertension: The Task Force for the Mangement of Arterial Hypertension
of the European Society of Hypertesnion (ESH) and of the European
Society of Cardiology (ESC).
Eur Heart J.
2207;
28
1462-1536
MissingFormLabel
- 16
Mc Gubbin J W, Green J H, Page I H.
Baroreceptor function in chronic renal hypertension.
Circ Res.
1956;
4
2560-72
MissingFormLabel
- 17
Middeke M.
Hypertensiologie 2007.
Dtsch Med Wochenschr.
2007;
132
1368-1370
MissingFormLabel
- 18
Middeke M.
Hypertensiologie 2009.
Dtsch Med Wochenschr.
2009;
142
1312-15
MissingFormLabel
- 19 National Institutes of
Health .Device Based Therapy in Hypertension Extension
Trial (DEBuT-HET). Available at: http://clinicaltrials.gov/ct2/show/NTC00710294.
MissingFormLabel
- 20
Wolf-Maier K, Cooper R. et al .
Hypertension
prevalance and blood pressure levels in 6 European Countries; Canada,
and the United States.
J Am Med Assoc.
2003;
289
2363-69
MissingFormLabel
- 21
Rosamond W, Flegal K, Furie K. et al .
Heart disease and stroke statistics 2008
update: a report from the American Heart Association statistics
committee and stroke statistics subcommittee.
Circulation.
2008;
117
76-80
MissingFormLabel
- 22 Rothstein M, De Leeuw P, Elletson M. et al .Chronic treatment of resistant hypertension
with an implantable device: interim 2 year results of two studies
of the Rheos( Hypertension System. Late-Breakiong Clinical Trials
III: Emerging Technologies Session 407 ACC,. Orlando; March 30th, 2009
MissingFormLabel
- 23
Schmidli S, Savolainen H, Eckstein F. et al .
Acute device-based blood pressure reduction:
Electrcal activation of the carotid baroreflex in patients undergoing
elective carotid surgery.
Vascular.
2007;
15
63-9
MissingFormLabel
- 24
Scheffers I, Schmidli J, Kroon A A. et al .
Sustained blood pressure reduction by baroreflex
hypertension therapy with a chronically implanted system: long-term
data from the Rheos DEBuT-HT study in patient with resistant hypertension.
J Hypertens.
2007;
25
141-2
MissingFormLabel
- 25
Scheffers I JM, Schmidli J, Kroon A A. et al .
Sustained blood pressure reduction by baroreflex
hypertension therapy with a chronically implated system: 3-year
data from the Rheos Debut-Ht Study in patients with resistent hypertension.
J Hypertens.
2209;
27
(Suppl 1)
S421
MissingFormLabel
- 26
Scheffers I, Kroon A, De Leeuw P.
Renal haemodynamics during chronic therapy with electrical stimulation
of the carotid sinus in human.
J Hypertens.
2008;
28
(Suppl1)
S465
MissingFormLabel
- 27
Schwartz P J. et al .
Long term vagal stimulation in patients
with advanced heart failure. First experience in man.
Eur
J Heart Fail.
2008;
10
884-91
MissingFormLabel
- 28
Peters T K.
Therapeutische Blutdrucksenkung durch ein aktives Implantat:
Ein neues Verfahren zur Behandlung der medikamentös therapierefraktären
Hypertonie.
J Hypert.
2008;
12
22-7
MissingFormLabel
- 29
Wustmann K, Kucera J P, Scheffers I. et al .
Effects of chronic baroreflex stimulation
on the autonomic cardiovascular regulation in patients with drug-resistant
arterial hypertension.
Hypertension.
2009;
54
530-6
MissingFormLabel
- 30
Zucker I H, Hackley J F, Cornisch K G. et al .
Chronic baroreflex activation enhances
survival in dogs with pacing-induced heart failure.
Hypertension.
2007;
50
1201-8
MissingFormLabel
- 31
Cameron T.
Safety and efficacy of spinal cord stimulation for the treatment
of chronic pain: a 20 year literature review.
J Neurosurg.
2004;
100
254-67
MissingFormLabel
- 32
Kumar K, Buchser E, Linderoth B. et al .
Avoiding complication from spinal cord
stimulation: practical recommendations from an international panel
of experts.
Neuromodulation.
2007;
10
24-33
MissingFormLabel
Dr. Siegfried Eckert
Kardiologische Klinik, Herz- und Diabeteszentrum
Nordrhein-Westfalen, Klinik der Ruhr-Universität Bochum
Georgstraße 11
32545 Bad Oeynhausen
Phone: 05731/970
Fax: 05731/971874
Email: seckert@hdz-nrw.de